Sciele Home Sciele Products Page Product Development Pipeline Sciele Business Development Sciele Investor Relations Sciele Career Page Sciele Contact Information
 

Pravastatin/Fenofibrate Combination Therapy

Press Releases:

Sciele Completes Enrollment of Patients in Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate

Sciele Begins to Enroll Patients in a Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate

Sciele Pharma Signs a Development and Marketing Agreement for a Novel Combination of Fenofibrate and Pravastatin to Treat Mixed Dyslipidemia

Presentations:

 

Back to Pipeline

Adobe® Reader® is required to view our Prescribing Information documents;
click here to download this free program.

This web site and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.